poisar

Stocks · News reference

Medtronic, Dell and 3 Stocks to Watch Heading Into Tuesday

Avi Kapoor

With U.S. stock futures trading slightly lower this morning on Tuesday, here are some of the stocks that may grab investor focus today,

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

CANGDELLMDTPANWPXS
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Researchandmarkets.Com

    Global Sacral Neuromodulation Market Size, Share, Trends and Forecast 2026-2036: Rechargeable, MRI-Compatible Systems Drive 11.1% CAGR

    The global sacral neuromodulation market is estimated at USD 1.37 billion in 2026 and projected to reach USD 3.92 billion by 2036, growing at 11.1% CAGR. Market expansion is driven by rising prevalence of urinary and fecal incontinence, aging populations, and technological advancements in rechargeable and MRI-compatible devices. Key challenges include high procedural costs and complex regulatory requirements. North America leads the market while Asia-Pacific is expected to register the fastest growth.

    MDTBSXABTLIVN
  3. Na

    Orchestra BioMed Announces Pricing of Public Offering

    Orchestra BioMed (OBIO) announced the pricing of an underwritten public offering of 15 million shares at $5.00 per share, expected to raise $75 million in gross proceeds. The company plans to use the funds to advance its AVIM Therapy program and BACKBEAT clinical trial for hypertension treatment, as well as its Virtue SAB program for coronary in-stent restenosis, alongside other research and development initiatives.

    OBIOMDT
  4. Robert Izquierdo

    Palo Alto Networks vs. Zscaler: Which Cybersecurity Stock Is a Better Buy Going Into 2027?

    The article compares two leading cybersecurity stocks: Palo Alto Networks (PANW) and Zscaler (ZS). While both are high-growth companies in the expanding cybersecurity market, Palo Alto Networks is recommended as the better buy for 2027 due to its larger scale ($11.5B revenue vs. $3.4B), profitability ($307M net income vs. $63.2M net loss), and successful platformization strategy. However, both stocks trade at elevated valuations with forward P/E ratios of 75x and 41.5x respectively, and both experienced recent price declines.

    PANWZSMSFTGOOGGOOGL